1. Home
  2. HNI vs ACAD Comparison

HNI vs ACAD Comparison

Compare HNI & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HNI
  • ACAD
  • Stock Information
  • Founded
  • HNI 1944
  • ACAD 1993
  • Country
  • HNI United States
  • ACAD United States
  • Employees
  • HNI N/A
  • ACAD N/A
  • Industry
  • HNI Office Equipment/Supplies/Services
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • HNI Consumer Discretionary
  • ACAD Health Care
  • Exchange
  • HNI Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • HNI 2.4B
  • ACAD 2.8B
  • IPO Year
  • HNI N/A
  • ACAD 2004
  • Fundamental
  • Price
  • HNI $51.26
  • ACAD $17.89
  • Analyst Decision
  • HNI Strong Buy
  • ACAD Buy
  • Analyst Count
  • HNI 1
  • ACAD 19
  • Target Price
  • HNI $63.00
  • ACAD $26.17
  • AVG Volume (30 Days)
  • HNI 429.1K
  • ACAD 4.2M
  • Earning Date
  • HNI 02-20-2025
  • ACAD 02-25-2025
  • Dividend Yield
  • HNI 2.55%
  • ACAD N/A
  • EPS Growth
  • HNI 159.58
  • ACAD N/A
  • EPS
  • HNI 2.56
  • ACAD 0.78
  • Revenue
  • HNI $2,563,700,000.00
  • ACAD $929,236,000.00
  • Revenue This Year
  • HNI $5.42
  • ACAD $36.78
  • Revenue Next Year
  • HNI $2.73
  • ACAD $8.19
  • P/E Ratio
  • HNI $20.02
  • ACAD $23.02
  • Revenue Growth
  • HNI 10.36
  • ACAD 47.06
  • 52 Week Low
  • HNI $40.22
  • ACAD $14.15
  • 52 Week High
  • HNI $58.42
  • ACAD $29.29
  • Technical
  • Relative Strength Index (RSI)
  • HNI 52.82
  • ACAD 54.79
  • Support Level
  • HNI $45.83
  • ACAD $16.61
  • Resistance Level
  • HNI $51.24
  • ACAD $18.23
  • Average True Range (ATR)
  • HNI 1.10
  • ACAD 0.72
  • MACD
  • HNI 0.44
  • ACAD -0.02
  • Stochastic Oscillator
  • HNI 92.81
  • ACAD 47.74

About HNI HNI Corporation

HNI Corp is a provider of office furniture and hearth products. The company generates the bulk of its revenue from its workplace furnishing, which consists of panel-based and freestanding furniture systems, seating, storage, tables, and architectural products. These products are sold through a national system of dealers, wholesalers, and office product distributors but also directly to end-user customers and federal, state, and local governments. Residential building products include a full array of gas, wood, electric, and pellet-fueled fireplaces, inserts, stoves, facings, and accessories. The company has operations in the United States, Canada, Mainland China, Hong Kong, India, Mexico, and Taiwan.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Share on Social Networks: